Search

everythinglearnresearchcommunity

for

Search:↓

Hirsutism can be caused by various conditions besides PCOS, and it's important to treat the underlying issue and manage symptoms with medication and cosmetic approaches.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

Skin aging is caused by stem cell damage and can potentially be delayed with treatments like antioxidants and stem cell therapy.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

Various treatments exist for hair loss, but more research is needed for better options.

PRP treatment may promote hair growth and improve hair density in women with AGA, but more research is needed.

Early diagnosis and treatment of PCOS in teenagers can help prevent more severe adult PCOS.

Family-based treatment is the best outpatient care for stable teens with anorexia, and more research is needed on medication and treatment effectiveness for young people with eating disorders.

A group has developed therapies that show promise for treating cancer and various other conditions.

Thyroid disease can cause hair loss and treating thyroid problems might help with hair disorders.

Transgender and gender-diverse adults on hormone therapy often face drug-hormone interactions, especially with multiple psychotropic medications.

Spironolactone is safe for treating female hair loss, but the safety of other drugs is uncertain.

The article suggests renaming Polycystic Ovarian Syndrome (PCOS) to "Hyperandrogenic Persistent Ovulatory Dysfunction Syndrome" (HA-PODS) for accuracy and consistency, but no final decision was made.

MicroRNAs could be key biomarkers and therapeutic targets for PCOS.

Treating hair loss effectively may require a multi-sided approach, using different treatments together, and topical treatments could be more effective and safer than oral ones.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

Women with PCOS are more likely to develop kidney stones, especially those with certain PCOS types.

Placenta products might help with hair loss, but more research is needed.

Testosterone helps human pancreatic cells increase insulin release.

The new oral testosterone pill normalized testosterone levels and lowered SHBG in men with low testosterone.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

A male with aromatase deficiency improved bone health with estradiol treatment.

Low estrogen compared to androgen may cause female hair loss.